/AGL.L
AGL.L Stock - ANGLE plc
Healthcare|Medical - Diagnostics & ResearchLSE
$1.01-3.33%
$0.04 (-3.33%) • Dec 22
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.12
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AGL.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.00 – $1.03
TARGET (TP)$1.17
STOP LOSS$0.93
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.08
52W High$17.45
52W Low$1.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.86M | $2.19M | $1.04M | $1.01M | $762,000 |
| Gross Profit | $1.78M | $-408,000 | $613,000 | $711,000 | $597,000 |
| Gross Margin | 62.2% | -18.7% | 58.9% | 70.2% | 78.3% |
| Operating Income | $-15,096,000 | $-21,759,000 | $-24,207,000 | $-17,235,000 | $-13,731,000 |
| Net Income | $-14,225,000 | $-20,132,000 | $-21,686,000 | $-15,012,000 | $-11,606,000 |
| Net Margin | -497.0% | -921.0% | -2083.2% | -1481.9% | -1523.1% |
| EPS | $-0.05 | $-0.08 | $-0.09 | $-0.07 | $-0.07 |
Company Overview
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AGL.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.03
Q3 2025
EPS Surprise History
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 9, 2025 | — | $-0.03 | — | — |
Q2 2025 | May 28, 2025 | — | $-0.01 | — | — |
Q3 2024 | Sep 26, 2024 | — | $-0.01 | — | — |
Q2 2024 | Jun 5, 2024 | — | $-0.01 | — | — |
Q1 2024 | Mar 19, 2024 | — | $-0.02 | — | — |
Q1 2024 | Feb 7, 2024 | — | $-0.02 | — | — |
Q3 2023 | Sep 7, 2023 | — | $-0.04 | — | — |
Q2 2023 | Jun 2, 2023 | — | $-0.02 | — | — |
Q2 2023 | Apr 21, 2023 | — | $-0.05 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.02 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.04 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.02 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.03 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.04 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.02 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.04 | — | — |
Q4 2020 | Oct 29, 2020 | — | $-0.03 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.02 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about AGL.L
What is AGL.L's current stock price?
ANGLE plc (AGL.L) is currently trading at $1.01 per share. The stock has moved -3.33% today.
What is the analyst price target for AGL.L?
No analyst price targets are currently available for this stock.
What sector is ANGLE plc in?
ANGLE plc operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the LSE exchange.
What is AGL.L's market cap?
ANGLE plc has a market capitalization of $0.00 billion, making it a small-cap company.
Does AGL.L pay dividends?
No, ANGLE plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCIZ.L
Cizzle Biotechnology Holdings Plc
$1.55
Mkt Cap: $0.6B
CNSL.L
Cambridge Nutritional Sciences plc
$1.95
Mkt Cap: $0.5B
FUM.L
Futura Medical plc
$1.08
Mkt Cap: $0.3B
GDR.L
Genedrive Plc
$0.80
Mkt Cap: $0.5B
GENI.L
GENinCode plc
$2.45
Mkt Cap: $0.7B
OBD.L
Oxford BioDynamics Plc
$0.23
Mkt Cap: $0.5B
OPTI.L
OptiBiotix Health Plc
$6.75
Mkt Cap: $0.7B
PRM.L
Proteome Sciences plc
$2.35
Mkt Cap: $0.7B
RUA.L
RUA Life Sciences plc
$12.25
Mkt Cap: $0.8B
VRCI.L
Verici Dx plc
$0.78
Mkt Cap: $1.2B
Explore stocks similar to AGL.L for comparison